Ardelyx Reports Real-World XPHOZAH Data at ASN Kidney Week

Real-world data showed serum phosphate reductions of 0.80–1.55 mg/dL at six months after XPHOZAH initiation. At 180 days, 16%–41% of patients had reached below 5.5 mg/dL, and 60%–70% remained on therapy.